Cufsniff Respules: Your Premier PCD Pharma Franchise in Respiratory Care

About Ambroxol Hydrochloride 15 mg: A Potent Mucolytic for Breathing Relief

Tapping into the High-Demand Market of Cough and Respiratory Disorders

Why Cufsniff Respules is a High-Profit Opportunity for Distributors

Partnering for Success with a Quality-Assured Product
Join Our Pharma Franchise for Unmatched Business Support

Home/Products /ambroxol-hydrochloride-15-mg-respules

Cufsniff 15 Respules

Composition : Ambroxol Hydrochloride 15 mg Respule

Dosage Form : Respule

Packaging Type : Pack

Packaging : 4x5x2ml

Price : ₹1/-

Cufsniff Respules are a specialized and highly effective medication containing Ambroxol Hydrochloride 15 mg, formulated as a solution for nebulization. As a potent mucolytic agent, it is designed to treat respiratory conditions where thick or excessive mucus is a primary problem. Ambroxol works by breaking down the fibrous structure of phlegm, thinning it and making it easier to cough out. This action provides significant relief from symptoms like chest congestion, shortness of breath, and a persistent cough, thereby improving breathing and overall respiratory function. The precise and effective delivery via a nebulizer ensures that the medication reaches the lungs directly, providing quick and reliable relief for patients.

The respiratory segment of the Indian pharmaceutical market is a high-volume, high-growth sector with a consistently high demand. The rising prevalence of respiratory disorders, fueled by factors like air pollution, seasonal allergies, and an aging population, ensures that products like Cufsniff Respules are a staple in both hospital and home-care settings. The continuous need for effective management of acute and chronic respiratory conditions makes this product a strategic choice for any distributor seeking a stable and profitable business. The market for this essential molecule is robust, with a constant prescription flow from specialists like pulmonologists and pediatricians.

We are dedicated to empowering our franchise partners with all the tools necessary for success. Our product, manufactured in a WHO-GMP certified facility, ensures impeccable quality, efficacy, and safety, which is crucial for building trust with healthcare professionals. We provide a complete promotional and marketing kit, including visual aids and product literature, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of this top-quality respiratory medicine.

Read More

About the Product

Cufsniff Respules are a specialized and highly effective medication containing Ambroxol Hydrochloride 15 mg, formulated as a solution for nebulization. As a potent mucolytic agent, it is designed to treat respiratory conditions where thick or excessive mucus is a primary problem. Ambroxol works by breaking down the fibrous structure of phlegm, thinning it and making it easier to cough out. This action provides significant relief from symptoms like chest congestion, shortness of breath, and a persistent cough, thereby improving breathing and overall respiratory function. The precise and effective delivery via a nebulizer ensures that the medication reaches the lungs directly, providing quick and reliable relief for patients.

The respiratory segment of the Indian pharmaceutical market is a high-volume, high-growth sector with a consistently high demand. The rising prevalence of respiratory disorders, fueled by factors like air pollution, seasonal allergies, and an aging population, ensures that products like Cufsniff Respules are a staple in both hospital and home-care settings. The continuous need for effective management of acute and chronic respiratory conditions makes this product a strategic choice for any distributor seeking a stable and profitable business. The market for this essential molecule is robust, with a constant prescription flow from specialists like pulmonologists and pediatricians.

We are dedicated to empowering our franchise partners with all the tools necessary for success. Our product, manufactured in a WHO-GMP certified facility, ensures impeccable quality, efficacy, and safety, which is crucial for building trust with healthcare professionals. We provide a complete promotional and marketing kit, including visual aids and product literature, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of this top-quality respiratory medicine.

May include hoarseness, throat irritation, dry mouth, or cough. Long-term use can rarely lead to oral thrush (fungal infection). Rinse mouth after each use to prevent this.

Persistent asthma (mild to severe) Chronic obstructive pulmonary disease (COPD) Allergic and non-allergic airway inflammation Nebulization therapy in children and adults as prescribed

Use only with a nebulizer under medical supervision. Not for acute asthma attacks – use a rescue inhaler for quick relief. Rinse mouth after inhalation to prevent infections. Regular use is important for effectiveness – do not skip doses. Do not stop suddenly without consulting your doctor.

Store below 25°C. Protect from light and moisture. Do not freeze. Keep out of reach of children. Use immediately after opening the respule.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation